Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barclays Analyst Increases Price Target on ONEOK to 80

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
TMUS stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Theresa Chen, a financial expert at Barclays, has reaffirmed her Equal-Weight rating on ONEOK (NYSE: OKE) and increased the price target to $80, up from $73. This adjustment reflects her optimistic view on the company’s potential growth. It is crucial to keep in mind that analysts’ opinions and price targets are fluid and can be altered due to market conditions and individual company developments.

March 7, 2024

BYON Stock Shows Strong Performance with Bullish Investor Sentiment on March 7, 2024

On March 7, 2024, BYON stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend over the long term.

The price of BYON shares increased by $0.50 since the market last closed, representing a 1.42% rise. The stock opened at $35.73, which was $0.61 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects for the day.

BYON’s price momentum and positive price change on March 7th indicate that investors are bullish on the stock. The stock’s performance suggests that there may be strong buying interest in BYON, potentially driven by positive news or developments related to the company.

BYON Stock Performance Analysis: Revenue and Net Income Decline in Q1 2024

On March 7, 2024, BYON stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.56 billion for the past year, which represented a 19.08% decrease compared to the previous year. However, the total revenue remained flat at $384.46 million for the last quarter. In terms of net income, BYON reported a net loss of $307.84 million for the past year, which was a significant decrease of 773.66% compared to the previous year. However, the net loss improved slightly to $160.99 million for the last quarter, showing a 0.0% increase compared to the previous quarter. Earnings per share (EPS) for BYON also showed a decline in performance. The company reported an EPS of -$6.81 for the past year, which was a decrease of 756.43% compared to the previous year. The EPS further decreased to -$3.55 for the last quarter, representing a 154.59% decrease compared to the previous quarter. Overall, the financial performance of BYON on March 7, 2024, reflected a challenging year with declining total revenue, net income, and earnings per share. Investors may have concerns about the company’s ability to turn around its financial performance and improve profitability in the upcoming quarters. It is important for investors to closely monitor the company’s financial reports and any updates from management to make informed decisions regarding BYON stock.

Tags: BYON
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Jerry Hogge Appointed as Executive Vice President and COO of MultiPlan Corporation

Green energy

Breakthrough in Carbon Capture Technology by ESG Clean Energy Subsidiary of Camber Energy

Revolutionizing Mental Health Care Neuronetics and Transformations Care Network Forge GameChanging Partnership

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com